PATH's Approach to Product Introduction in Developing Countries

Health interventions developed for wealthy nations are difficult to introduce in developing countries due to a lack of sufficient technological, financial, political, or infrastructural resources. Increasingly, however, product developers are creating new technologies that meet the needs of low‐resource settings. Experience has shown that many activities must be undertaken to prepare health systems to accept and embrace new, improved, or under‐utilized health technologies. This article describes three health technologies-a diagnostic test for vitamin A deficiency, new cervical cancer vaccines, and the vaccine vial monitor-that PATH, a global health organization, has helped advance for developing‐country markets. © 2008 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:5080-5083, 2008